Buprenorphine prescribing practice trends and attitudes among New York providers
Buprenorphine prescribing practice trends and attitudes among New York providers
复制标题
DOI：
10.1016/j.jsat.2016.10.005
复制
发表时间：
2017-03-01
影响因子：
3.9
通讯作者：
Lee, Joshua D.
中科院分区：
文献类型：
--
作者：
Kermack, Andrea;Flannery, Mara;Lee, Joshua D.
丁丙诺啡基于办公室的阿片类药物维持是阿片类药物使用障碍的一种越来越常见的治疗形式。然而，总处方量并没有跟上目前阿片类药物和过量流行的步伐，在服务不足的人群中仍然很难获得。本研究旨在评估当前供应商的态度和临床实践中的目标样本主要是纽约市公共部门丁丙诺啡处方。一项横断面在线调查有目的地对纽约市的丁丙诺啡处方者进行了抽样调查，重点关注那些为医疗补助和无保险患者人群服务的处方者。专家审查当地供应商网络，雪球转介，并在人的网络产生了一个电子邮件列表，其中收到了一个调查链接。一个简短的25个问题的工具询问提供者和实践人口统计学，规定的做法，包括诱导方法和对常见热点话题的态度（例如，丁丙诺啡转移、处方者患者限制、保险问题、辅助治疗）。在132封电子邮件邀请中，N = 72名受访者在2016年1月至4月期间完成（n = 64）或部分完成（n = 8）调查。大多数（79%）是非精神科专业的医疗补助提供者（72%），在医院或社区全科诊所工作（51%），以及成瘾医学或精神病学的董事会认证（58%）。实践规模通常为100名患者或更少（71%）;许多供应商（64%）单独处方丁丙诺啡
Buprenorphine office-based opioid maintenance is an increasingly common form of treatment for opioid use disorders. However, total prescribing has not kept pace with the current opioid and overdose epidemic and access remains scarce among the underserved. This study sought to assess current provider attitudes and clinical practices among a targeted sample of primarily New York City public sector buprenorphine prescribers. A cross-sectional online survey purposefully sampled buprenorphine prescribers in NYC with a focus on those serving Medicaid and uninsured patient populations. Expert review of local provider networks, snowball referrals, and in-person networking generated an email list, which received a survey link. A brief 25-question instrument queried provider and practice demographics, prescribing practices including induction approaches and attitudes regarding common hot topics (e.g., buprenorphine diversion, prescriber patient limits, insurance issues, ancillary treatments). Of 132 email invitations, N = 72 respondents completed (n = 64) or partially completed (n = 8) the survey between January and April 2016. Most (79%) were Medicaid providers in non-psychiatric specialties (72%), working in a hospital-based or community general practice (51%), and board-certified in addiction medicine or psychiatry (58%). Practice sizes were generally 100 patients or fewer (71%); many providers (64%) individually prescribed buprenorphine